$VEEA
VEEA INC.

2024 Q2 Form 10-Q Financial Statement

#000121390024077054 Filed on September 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$789.2K
YoY Change 36.32%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $4.015M
YoY Change -17.17%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $3.226M
YoY Change -24.43%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.969K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $66.88K
Receivables
Other Receivables
Total Short-Term Assets $285.0K
YoY Change 286.33%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $4.793M
YoY Change -0.39%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $36.37M
YoY Change -36.89%
TOTAL ASSETS
Total Short-Term Assets $285.0K
Total Long-Term Assets $36.37M
Total Assets $36.66M
YoY Change -36.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.441M
YoY Change 14.35%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $8.441M
Total Long-Term Liabilities
Total Liabilities $9.516M
YoY Change 21.91%
SHAREHOLDERS EQUITY
Retained Earnings -$16.31M
YoY Change 38.94%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$9.231M
YoY Change
Total Liabilities & Shareholders Equity $36.66M
YoY Change -36.47%

Cashflow Statement

Concept 2024 Q2
OPERATING ACTIVITIES
Net Income $3.226M
YoY Change -24.43%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
PLUM ACQUISITION CORP. I
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity File Number
EntityFileNumber
001-40218
dei Entity Address Address Line1
EntityAddressAddressLine1
2021 Fillmore St. #2089
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94115
dei City Area Code
CityAreaCode
(415)
dei Local Phone Number
LocalPhoneNumber
683-6773
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1969 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94703 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
66875 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
50853 usd
CY2024Q2 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
216134 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
284978 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
145556 usd
CY2024Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
36374892 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
35555976 usd
CY2024Q2 us-gaap Assets
Assets
36659870 usd
CY2023Q4 us-gaap Assets
Assets
35701532 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5661736 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4587330 usd
CY2024Q2 plmi Ordinary Shares To Be Redeemed Current
OrdinarySharesToBeRedeemedCurrent
216134 usd
CY2024Q2 plmi Advance From Sponsor Current
AdvanceFromSponsorCurrent
213050 usd
CY2024Q2 plmi Subscription Liability Current
SubscriptionLiabilityCurrent
699950 usd
CY2023Q4 plmi Subscription Liability Current
SubscriptionLiabilityCurrent
1567406 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8441417 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7736027 usd
CY2024Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1074447 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1643271 usd
CY2024Q2 us-gaap Liabilities
Liabilities
9515864 usd
CY2023Q4 us-gaap Liabilities
Liabilities
9379298 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7082596 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6098498 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16314281 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15333039 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-9230886 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9233742 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36659870 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35701532 usd
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
789241 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
578954 usd
us-gaap Costs And Expenses
CostsAndExpenses
1708374 usd
us-gaap Costs And Expenses
CostsAndExpenses
1732236 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-789241 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-578954 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1708374 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1732236 usd
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3855365 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1978245 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-568824 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
44241 usd
CY2023Q2 plmi Change In Fair Value Of Forward Purchase Agreement
ChangeInFairValueOfForwardPurchaseAgreement
-633205 usd
plmi Change In Fair Value Of Forward Purchase Agreement
ChangeInFairValueOfForwardPurchaseAgreement
-308114 usd
plmi Issuance Of Forward Purchase Agreement
IssuanceOfForwardPurchaseAgreement
-308114 usd
plmi Reduction Of Deferred Underwriter Fee Payable
ReductionOfDeferredUnderwriterFeePayable
328474 usd
CY2024Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
234465 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
106416 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
651742 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
134931 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
394128 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
626320 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
810050 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
3715287 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4015028 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3131354 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
727132 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3864589 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
3225787 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2552400 usd
us-gaap Net Income Loss
NetIncomeLoss
-981242 usd
us-gaap Net Income Loss
NetIncomeLoss
2132353 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9233742 usd
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
550922 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
245375 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-4207029 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-13746318 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
12829 usd
CY2024Q2 plmi Adjustments To Additional Paid In Forgiveness Of Promissory Notes
AdjustmentsToAdditionalPaidInForgivenessOfPromissoryNotes
1760944 usd
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
484128 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
3225787 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-9230886 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-15297513 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
10844098 usd
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
3568966 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
256635 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-420047 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-8185793 usd
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
786320 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
166966 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2552400 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6252747 usd
us-gaap Net Income Loss
NetIncomeLoss
-981242 usd
us-gaap Net Income Loss
NetIncomeLoss
2132353 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
810050 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
3715287 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-568824 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
44241 usd
plmi Reduction Of Deferred Underwriter Fee Payable
ReductionOfDeferredUnderwriterFeePayable
328474 usd
plmi Issuance Of Forward Purchase Agreement
IssuanceOfForwardPurchaseAgreement
-308114 usd
plmi Change In Fair Value Of Forward Purchase Agreement
ChangeInFairValueOfForwardPurchaseAgreement
-308114 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
651742 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
134931 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
16022 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
9254 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
69256 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
96826 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1074406 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1213199 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-580734 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-431465 usd
plmi Payments For Investment Of Cash In Trust Account
PaymentsForInvestmentOfCashInTrustAccount
225000 usd
plmi Payments For Investment Of Cash In Trust Account
PaymentsForInvestmentOfCashInTrustAccount
640000 usd
plmi Proceeds From Cash Withdraw Trust Account For Redemptions
ProceedsFromCashWithdrawTrustAccountForRedemptions
273112312 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-225000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
272472312 usd
plmi Proceeds From The Subscription Liability
ProceedsFromTheSubscriptionLiability
499950 usd
plmi Proceeds From The Subscription Liability
ProceedsFromTheSubscriptionLiability
755944 usd
plmi Proceeds Advance From Sponsor
ProceedsAdvanceFromSponsor
213050 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
273112312 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
250000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
713000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-272106368 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-92734 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-65521 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94703 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86401 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1969 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20880 usd
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1035050 usd
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
4355287 usd
us-gaap Notes Issued1
NotesIssued1
1760944 usd
plmi Ordinary Share To Be Redeemed
OrdinaryShareToBeRedeemed
216134 usd
us-gaap Stock Issued1
StockIssued1
258204 usd
us-gaap Stock Issued1
StockIssued1
423601 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 1 —  ORGANIZATION AND BUSINESS OPERATIONS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Plum Acquisition Corp. I (the “Company” or “Plum”) was incorporated as a Cayman Islands exempted company on January 11, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As previously reported, on November 27, 2023, the Company executed a Business Combination Agreement by and between the Company, Plum SPAC Merger Sub, Inc. (“Merger Sub”), a Delaware corporation and wholly-owned subsidiary of Plum, and Veea Inc., a Delaware corporation (“Veea”) (the “Business Combination Agreement”). Pursuant to the Business Combination Agreement, the Company and Veea are working toward closing their business combination (the “Business Combination”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2024, the Company had not commenced any operations. All activity for the period from January 11, 2021 (inception) through June 30, 2024 relates to the Company’s formation and the initial public offering (“IPO”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a business combination. The Company believes it will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on investments in the Company’s Trust account and will recognize changes in the fair value of the warrant liabilities as other income (expense).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s Sponsor is Plum Partners, LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s IPO was declared effective on March 15, 2021 (the “Effective Date”). On March 18, 2021, the Company consummated the initial public offering (the “Public Offering” or “IPO”) of 30,000,000 units (the “Units), at $10.00 per Unit, generating gross proceeds of $300,000,000, which is discussed in Note 3.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simultaneously with the closing of the IPO, the Company consummated the sale of 6,000,000 warrants (the “Private Placement Warrants”), at a price of $1.50 per Private Placement Warrant, which is discussed in Note 4. Each warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, generating gross proceeds of $9,000,000, which is described in Note 4.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company granted the underwriter a 45-day option from March 18, 2021 to purchase up to an additional 4,500,000 Units to cover over-allotments, if any, at the IPO price less the underwriting discounts and commissions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The underwriter partially exercised the over-allotment option on April 14, 2021 and purchased 1,921,634 Units at $10.00 per Unit. Simultaneously with the issuance and sale of the Units on April 14, 2021, the Company consummated the private placement with the Sponsor for an aggregate of 256,218 warrants to purchase Class A Ordinary Shares for $1.50 per warrant generating total proceeds of $384,327. On April 14, 2021, $19,216,340, net of the underwriter discount, was deposited in the Company’s Trust account.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A total of $19,216,340 was placed in a U.S.-based trust account maintained by Continental Stock Transfer &amp; Trust Company, acting as trustee. Transaction costs of the IPO and the exercise of the over-allotment option amounted to $18,336,269 consisting of $6,384,327 of underwriting discount, $11,172,572 of deferred underwriting discount, and $779,370 of other offering costs. Of the transaction costs, $538,777 is included in transaction costs on condensed consolidated statements of operations and $17,797,492 is included in condensed consolidated statements of changes in shareholders’ deficit.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the closing of the Public Offering on March 18, 2021 and the partial exercise of the underwriter’s over-allotment option, $319,216,340 (approximately $10.00 per Unit) from the net proceeds of the sale of the Units in the Public Offering, including the proceeds from the sale of the Private Placement Warrants, was deposited in a trust account (“Trust Account”) located in the United States at Goldman Sachs, with Continental Stock Transfer &amp; Trust Company acting as trustee, and was invested in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invests only in direct U.S. government treasury obligations. The Trust Account now holds the funds in a demand deposit account. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the IPO and the sale of the Private Placement Warrants will not be released from the Trust Account (1) to the Company, until the completion of our Business Combination, or (2) to the Public Shareholders, until the earliest of (i) the completion of the Business Combination, and then only in connection with those Class A ordinary shares that such shareholders properly elected to redeem, subject to the limitations described herein, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to provide holders of its Class A ordinary shares the right to have their shares redeemed in connection with the Business Combination or to redeem 100% of the public shares if the Company does not complete its Business Combination by September 14, 2024 (the “Combination Period”) or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares, and (iii) the redemption of the public shares if the Company has not consummated a business combination within the Combination Period, subject to applicable law. Public Shareholders who redeem their Class A ordinary shares in connection with a shareholder vote described in clause (ii) in the preceding sentence shall not be entitled to funds from the Trust Account upon the subsequent completion of an initial Business Combination or liquidation if the Company has not consummated an initial Business Combination within the Combination Period, with respect to such Class A ordinary shares so redeemed. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Public Shareholders (as defined below).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will provide shareholders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the IPO (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of the Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of the Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem all or a portion of their Public Shares upon the completion of the Business Combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes, if any, divided by the number of then-outstanding Public Shares, subject to certain limitations. The amount in the Trust Account is initially anticipated to be $10.00 per Public Share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These Public Shares have been classified as temporary equity upon the completion of the IPO in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company receives the approval of an ordinary resolution.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had until June 18, 2024, to complete a business combination. On June 14, 2024, the Company held a vote to extend the time the Company has to complete a business combination, the Company now has until September 14, 2024 to complete a business combination. However, if the Company is unable to complete a business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding public shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and its board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 31, 2024, the Company received a notice from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating the Company failed to hold an annual meeting of shareholders within twelve months of the end of its fiscal year ended December 31, 2022, as required by Nasdaq Listing Rule 5620(a). In accordance with Nasdaq Listing Rule 5810(c)(2)(G), the Company had 45 calendar days (or until March 16, 2024) to submit a plan to regain compliance and, if Nasdaq accepted the plan, Nasdaq could have granted the Company up to 180 calendar days from its fiscal year end (or until June 28, 2024) to regain compliance. The Company held its Annual General Meeting of the shareholders on March 25, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 18, 2024, the Company received a notice from the Listing Qualifications Department from Nasdaq stating that the Company has failed to complete a business combination pursuant to Nasdaq Listing Rule IM 5101-2, which requires that a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. The Company submitted a request for an oral hearing to request an extension to complete the Business Combination. The oral hearing was held on May 16, 2024. On May 24, 2024, the Nasdaq Hearings Panel granted the Company an exception until September 16, 2024 to complete the Business Combination provided that on or before September 16, 2024, the Company will demonstrate compliance with all applicable initial listing standards for the Nasdaq Capital Market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Extraordinary General Meeting and Redemption of Shares</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 15, 2023, Plum held an Extraordinary General Meeting of its Shareholders (1) to amend Plum’s amended and restated memorandum and articles of association (the “Articles”) to extend the date (the “Termination Date”) by which Plum has to consummate a business combination (the “Articles Extension”) from March 18, 2023 (the “Original Termination Date”) to June 18, 2023 (the “Articles Extension Date”) and to allow Plum, without another shareholder vote, to elect to extend the Termination Date to consummate a business combination on a monthly basis for up to nine times by an additional one month each time after the Articles Extension Date, by resolution of Plum’s board of directors if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until March 18, 2024, or a total of up to twelve months after the Articles Extension Date, unless the closing of Plum’s initial business combination shall have occurred prior to such date (the “Extension Amendment Proposal”) and (2) to amend the Articles to eliminate from the Articles the limitation that Plum may not redeem Class A ordinary shares to the extent that such redemption would result in Plum having net tangible assets (as determined in accordance with Rule 3a 51-1(g)(1)of the Securities Exchange Act of 1934, as amended) of less than $5,000,001 (the “Redemption Limitation”) in order to allow Plum to redeem Public Shares irrespective of whether such redemption would exceed the Redemption Limitation (the “Redemption Limitation Amendment Proposal”). The shareholders of Plum approved the Extension Amendment Proposal and the Redemption Limitation Amendment Proposal at the Shareholder Meeting and on March 15, 2023, Plum filed the amendment to the Articles with the Registrar of Companies of the Cayman Islands.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the vote to approve the Extension Amendment Proposal, the holders of 26,693,416 Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of $10.23 per share, for an aggregate redemption amount of $273,112,311.62.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to their Founder Shares, (ii) waive their redemption rights with respect to their Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) that would modify the substance or timing of the Company’s obligation to provide holders of the Class A ordinary shares the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of its public shares if the Company does not complete our initial Business Combination within the Combination Period or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares, (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to consummate an initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete its initial Business Combination within the prescribed time frame) and (iv) vote their Founder Shares and public shares in favor of our initial Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 13, 2023, Plum held an Extraordinary General Meeting of its Shareholders (“September Shareholder Meeting”) (1) to amend the Articles to extend Articles Extension Termination Date from the Articles Extension Date to December 18, 2023 (the “Second Articles Extension Date”) and to allow the Company, without another shareholder vote, to elect to extend the Termination Date to consummate a business combination on a monthly basis for up to six times by an additional one month each time after the Second Articles Extension Date, by resolution of the Company’s board of directors if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until June 18, 2024, or a total of up to nine months after the Termination Date, unless the closing of the Company’s initial business combination shall have occurred prior to such date (the “Second Extension Amendment Proposal”) and (2) to authorize a reduction in the funds held in the Trust Account to an amount equal to $20,000,000 (the “Trust Reduction”), which amount will be used to compulsorily redeem up to 3,228,218 Public Shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two business days prior to the redemption date, including interest (which interest shall be net of taxes payable), divided by the number of then-outstanding public shares (“Trust Reduction Proposal”). The shareholders of the Company approved the Second Extension Amendment Proposal and the Trust Reduction Proposal at the Shareholder Meeting and on September 13, 2023, the Company filed the amendment to the Articles with the Registrar of Companies of the Cayman Islands.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the vote to approve the Second Extension Amendment Proposal at the September Shareholder Meeting, (i) the Sponsor, as the sole holder of Class B Ordinary Shares, voluntarily elected to convert all Class B Ordinary Shares to Class A Ordinary Shares on a one-for-one basis in accordance with the Memorandum and Articles of Association (the “Class B Conversion”) and (ii) the holders of 1,972,625 Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of $10.72 per share, for an aggregate redemption amount of $21,142,261 (the “Redemption”). Upon completion of the Class B Conversion and the Redemption, 7,980,409 shares of Class A common stock, excluding 3,255,593 shares of Class A Ordinary Shares subject to possible redemption, and no shares of Class B common stock remain issued and outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As approved by its stockholders at the September Shareholder Meeting (the “EGM”), the Company filed an Amended and Restated Memorandum and Articles of Association (the “A&amp;R Charter”) on October 25, 2023, which (i) extended the date by which the Company has to consummate a business combination to December 18, 2023 and (ii) allowed the Company, without another shareholder vote, to elect to extend the Termination Date (as defined in the Proxy Statement) to consummate a business combination on a monthly basis for up to six times by an additional one month each time after December 18, 2023 (or such shorter period as necessary to comply with applicable listing requirements), by resolution of the Company’s board of directors, if requested by Plum Partners, LLC, and upon five days advance notice prior to the applicable termination date, until June 18, 2024, or a total of up to nine months after September 18, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An aggregate of 1,972,625 Class A ordinary shares of the Company were tendered for redemption in connection with the shareholders’ vote at the September Shareholder Meeting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 4, 2024, Plum held an Extraordinary General Meeting of its Shareholders (the “BC EGM”) to approve, among other things, Plum’s entry into the Business Combination Agreement and related matters, including domestication to become a Delaware entity. The shareholders approved all of the proposals at the BC EGM. An aggregate of 2,662,592 Class A ordinary shares of the Company were tendered for redemption in connection with the shareholders’ vote at the BC EGM, for an aggregate price of $29,926,030. Plum will redeem such Public Shares for a per-share price, payable in cash, equal to the pro rata portion of the remaining funds in the trust account, calculated as of two business days prior to the consummation of the Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 14, 2024, Plum held an Extraordinary General Meeting of its Shareholders (“June Shareholder Meeting”) to amend the Articles to extend Articles Extension Termination Date from the Articles Extension Date to September 14, 2024 (the “Third Articles Extension Date”). As approved by its shareholders at the June Shareholder Meeting, Plum filed an Amended and Restated Memorandum and Articles of Association (the “A&amp;R Charter”) on June 18, 2024 which extended the date by which the Company has to consummate a business combination to September 14, 2024. An aggregate of 19,230 Class A ordinary shares of the Company were tendered for redemption in connection with the shareholders’ vote at June Shareholder Meeting, for an aggregate price of $216,134, which were paid on or around August 23, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 13, 2024, Rigrodsky Law P.A. sent a demand letter to the Company, purportedly on behalf of a stockholder of the Company, alleging deficiencies in the draft registration statement on Form S-4 filed by the Company, with the U.S. Securities and Exchange Commission on January 5, 2024. As of the filing of this Quarterly Report the Company has received no further correspondence from Rigrodsky Law P.A.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Liquidity, Capital Resources, and Going Concern</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s liquidity needs up to March 18, 2021 had been satisfied through a capital contribution from the Sponsor of $25,000 (see Note 5) for the Founder Shares. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors, and third parties have committed to provide the Company Working Capital Loans (see Note 5). As of June 30, 2024, and December 31, 2023, the Company had $1,000,000 outstanding under Working Capital Loans.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2024, the Company had $1,969 in its operating bank account and a working capital deficit $8,156,439.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC 205-40, Presentation of Financial Statements—Going Concern”, management has determined that the Company has and will continue to incur significant costs in pursuit of its acquisition plans which raises substantial doubt about the Company’s ability to continue as a going concern. Moreover, we may need to obtain additional financing either to complete our initial Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our initial Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our initial Business Combination. If we are unable to complete our initial Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Accounts. In addition, following our initial Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Further, management has determined that if the Company is unable to complete a Business Combination by September 14, 2024 (the “Combination Period”), then the Company will cease all operations except for the purpose of liquidating. The date for mandatory liquidation and subsequent dissolution as well as the Company’s working capital deficit raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after the Combination Period. The Company intends to complete a Business Combination before the mandatory liquidation date.</p>
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-01-11
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
19216340 usd
plmi Transaction Costs
TransactionCosts
18336269 usd
plmi Sale Of Stock Underwriting Fees
SaleOfStockUnderwritingFees
6384327 usd
plmi Sale Of Stock Other Offering Costs
SaleOfStockOtherOfferingCosts
779370 usd
plmi Stock Issuance Costs
StockIssuanceCosts
538777 usd
plmi Transaction Costs For Sale Of Stock
TransactionCostsForSaleOfStock
17797492 usd
CY2024Q2 plmi Interest To Pay Dissolution Expenses
InterestToPayDissolutionExpenses
100000 usd
plmi Minimum Net Tangible Assets Upon Consummation Of Business Combination
MinimumNetTangibleAssetsUponConsummationOfBusinessCombination
5000001 usd
CY2024Q2 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
273112311.62 usd
CY2024Q2 plmi Public Share Redeemable Percentage
PublicShareRedeemablePercentage
1 pure
CY2023Q3 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
3228218 shares
us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
1972625 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2662592 shares
CY2024Q2 plmi Aggregate Price Amount
AggregatePriceAmount
29926030 usd
plmi Working Capital Loans
WorkingCapitalLoans
1000000 usd
CY2023 plmi Working Capital Loans
WorkingCapitalLoans
1000000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1969 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed consolidated financial statements is the determination of the fair value of the conversion option within the subscription, the forward purchase agreements and warrants liabilities. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates.</p>
CY2024Q2 us-gaap Assets Held In Trust
AssetsHeldInTrust
36591026 usd
CY2023Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
35555976 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p>
CY2024Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q2 us-gaap Derivative Credit Risk Valuation Adjustment Derivative Liabilities
DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities
2500000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2460894 usd
CY2024Q2 plmi Subscription Notess
SubscriptionNotess
699950 usd
CY2024Q2 plmi Sponsor Advanced
SponsorAdvanced
75000 usd
CY2024Q2 plmi Sponsor Advanced
SponsorAdvanced
100000 usd
CY2024Q2 plmi Sponsor Advanced
SponsorAdvanced
20000 usd
CY2024Q2 plmi Sponsor Advanced
SponsorAdvanced
18000 usd
plmi Sponsor Advanced
SponsorAdvanced
213050 usd
CY2023 plmi Sponsor Advanced
SponsorAdvanced
0 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
1000000 usd
CY2023 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
1000000 usd
CY2023Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
71956 shares
CY2023Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
12.5
CY2023Q4 plmi Consummation Shares
ConsummationShares
P10Y
CY2023Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
15 usd
CY2023Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
74695 shares
CY2023Q4 plmi Subscription Share Per Share
SubscriptionSharePerShare
12.5
CY2023Q4 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
340000 usd
CY2023Q4 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
200000 usd
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
180000 shares
CY2023Q4 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
800000 usd
CY2023Q4 plmi Investor Paid To Sponsor
InvestorPaidToSponsor
249975 usd
CY2023Q4 plmi Investor Paid To Sponsor
InvestorPaidToSponsor
250000 usd
CY2024Q1 plmi Investor Paid To Sponsor
InvestorPaidToSponsor
149975 usd
CY2024Q2 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
1425501 shares
CY2024Q2 plmi Subscription Liability Current
SubscriptionLiabilityCurrent
699950 usd
plmi Number Of Days After The Closing Of The Initial Business Combination To File With The Sec
NumberOfDaysAfterTheClosingOfTheInitialBusinessCombinationToFileWithTheSec
P20D
plmi Number Of Days After The Closing Of The Initial Business Combination For Registration Statement To Be Effective
NumberOfDaysAfterTheClosingOfTheInitialBusinessCombinationForRegistrationStatementToBeEffective
P60D
plmi Effective Day For Registration Statement To Be Effective
EffectiveDayForRegistrationStatementToBeEffective
P60D
us-gaap Class Of Warrant Or Right Reason For Issuing To Nonemployees
ClassOfWarrantOrRightReasonForIssuingToNonemployees
(A) the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” (as defined below) less the exercise price of the warrants by (y) the fair market value and (B) 0.361. The “fair market value” as used in this paragraph shall mean the volume weighted average price of the Class A ordinary shares for the 10 trading days ending on the trading day prior to the date on which the notice of exercise is received by the warrant agent.
plmi Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price
PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice
9.2
plmi Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Percentage
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Percentage
1.80 pure
CY2024Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0 usd
plmi Effective Days Of Lock Up Period
EffectiveDaysOfLockUpPeriod
P30D
CY2024Q2 plmi Deferred Underwriting Commissions Payable
DeferredUnderwritingCommissionsPayable
11172572 usd
CY2024Q2 plmi Maximum Threshold Reimbursement Of Attorney Fees By Sponsor
MaximumThresholdReimbursementOfAttorneyFeesBySponsor
5000 usd
plmi Final Amount Of Sponsor Capital
FinalAmountOfSponsorCapital
160000 usd
CY2023Q3 us-gaap Members Capital
MembersCapital
750000 usd
CY2023Q3 us-gaap Withdrawal From Contract Holders Funds
WithdrawalFromContractHoldersFunds
750000 usd
CY2023Q4 plmi Investor Paid To Sponsor
InvestorPaidToSponsor
249975 usd
CY2023Q4 plmi Investor Paid To Sponsor
InvestorPaidToSponsor
250000 usd
CY2024Q1 plmi Investor Paid To Sponsor
InvestorPaidToSponsor
149975 usd
plmi Founder Shares
FounderShares
1425501 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
plmi Founder Shares Forfeited Shares
FounderSharesForfeitedShares
644591 shares
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Holders of Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law.
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
usd
CY2023Q4 plmi Ordinary Shares To Be Redeemed Current
OrdinarySharesToBeRedeemedCurrent
usd
CY2023Q4 plmi Advance From Sponsor Current
AdvanceFromSponsorCurrent
usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2024Q2 plmi Change In Fair Value Of Forward Purchase Agreement
ChangeInFairValueOfForwardPurchaseAgreement
usd
plmi Change In Fair Value Of Forward Purchase Agreement
ChangeInFairValueOfForwardPurchaseAgreement
usd
CY2024Q2 plmi Issuance Of Forward Purchase Agreement
IssuanceOfForwardPurchaseAgreement
usd
CY2023Q2 plmi Issuance Of Forward Purchase Agreement
IssuanceOfForwardPurchaseAgreement
usd
plmi Issuance Of Forward Purchase Agreement
IssuanceOfForwardPurchaseAgreement
usd
CY2024Q2 plmi Reduction Of Deferred Underwriter Fee Payable
ReductionOfDeferredUnderwriterFeePayable
usd
CY2023Q2 plmi Reduction Of Deferred Underwriter Fee Payable
ReductionOfDeferredUnderwriterFeePayable
usd
plmi Reduction Of Deferred Underwriter Fee Payable
ReductionOfDeferredUnderwriterFeePayable
usd
plmi Reduction Of Deferred Underwriter Fee Payable
ReductionOfDeferredUnderwriterFeePayable
usd
plmi Issuance Of Forward Purchase Agreement
IssuanceOfForwardPurchaseAgreement
usd
plmi Change In Fair Value Of Forward Purchase Agreement
ChangeInFairValueOfForwardPurchaseAgreement
usd
plmi Proceeds From Cash Withdraw Trust Account For Redemptions
ProceedsFromCashWithdrawTrustAccountForRedemptions
usd
plmi Proceeds Advance From Sponsor
ProceedsAdvanceFromSponsor
usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Notes Issued1
NotesIssued1
usd
plmi Ordinary Share To Be Redeemed
OrdinaryShareToBeRedeemed
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001840317

Files In Submission

Name View Source Status
0001213900-24-077054-index-headers.html Edgar Link pending
0001213900-24-077054-index.html Edgar Link pending
0001213900-24-077054.txt Edgar Link pending
0001213900-24-077054-xbrl.zip Edgar Link pending
ea0213412-10q_plumacq1.htm Edgar Link pending
ea021341201ex31-1_plumacq1.htm Edgar Link pending
ea021341201ex31-2_plumacq1.htm Edgar Link pending
ea021341201ex32-1_plumacq1.htm Edgar Link pending
ea021341201ex32-2_plumacq1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
plmi-20240630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
plmi-20240630_def.xml Edgar Link unprocessable
plmi-20240630_pre.xml Edgar Link unprocessable
ea0213412-10q_plumacq1_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
plmi-20240630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
plmi-20240630_lab.xml Edgar Link unprocessable